Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$739K Sell
2,100
-113,500
-98% -$40.5M 0.01% 422
2025
Q4
$37.8M Buy
115,600
+108,800
+1,600% +$34.5M 0.19% 63
2025
Q3
$1.92M Buy
6,800
+5,600
+467% +$1.62M 0.01% 252
2025
Q2
$335K Sell
1,200
-300,700
-100% -$85.2M ﹤0.01% 284
2025
Q1
$94.1M Buy
301,900
+301,200
+43,029% +$88.9M 0.52% 28
2024
Q4
$182K Sell
700
-1,200
-63% -$356K ﹤0.01% 311
2024
Q3
$612K Buy
1,900
+700
+58% +$229K 0.01% 219
2024
Q2
$375K Buy
+1,200
New +$353K ﹤0.01% 332
2024
Q1
Sell
-3,500
Closed -$1.01M 474
2023
Q4
$1.01M Sell
3,500
-23,000
-87% -$6.27M 0.04% 102
2023
Q3
$7.12M Buy
26,500
+16,200
+157% +$4.04M 0.15% 76
2023
Q2
$2.29M Sell
10,300
-120,200
-92% -$27.9M 0.06% 133
2023
Q1
$31.5M Sell
130,500
-71,200
-35% -$17.5M 0.38% 53
2022
Q4
$53M Buy
201,700
+72,500
+56% +$19.4M 0.71% 32
2022
Q3
$29.1M Buy
129,200
+113,800
+739% +$27.6M 0.39% 55
2022
Q2
$3.75M Sell
15,400
-39,100
-72% -$9.58M 0.06% 227
2022
Q1
$13.2M Buy
+54,500
New +$12.5M 0.19% 112
2021
Q4
Sell
-10,000
Closed -$2.13M 213
2021
Q3
$2.13M Sell
10,000
-900
-8% -$207K 0.03% 393
2021
Q2
$2.66M Sell
10,900
-161,100
-94% -$39.6M 0.04% 258
2021
Q1
$42.8M Buy
+172,000
New +$41M 0.84% 20
2020
Q4
Sell
-6,100
Closed -$1.55M 282
2020
Q3
$1.55M Sell
6,100
-23,900
-80% -$5.92M 0.2% 90
2020
Q2
$7.08M Buy
30,000
+25,000
+500% +$5.7M 0.25% 100
2020
Q1
$1.01M Hold
5,000
0.04% 308
2019
Q4
$1.21M Buy
+5,000
New +$1.1M 0.03% 290

Other funds holding AMGN

Capula Management's AMGN Position: Q1 2026 in Review

Capula Management reduced its Amgen (AMGN) stake by 100% in Q1 2026, selling an estimated $39.2M and leaving 61 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Capula Management first reported a position in AMGN in Q1 2021 and has held it in 16 quarters since. The position peaked at $93.6M in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capula Management held 61 shares of Amgen worth $21.5K as of Q1 2026.
  • Capula Management sold 109,965 Amgen shares in Q1 2026, an estimated $39.2M.
  • Amgen made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1039 holding.
  • Capula Management first reported a position in Amgen in Q1 2021 and has held it in 16 quarters since.
  • Capula Management's Amgen position peaked at $93.6M in Q1 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.